Compounds > fluoxetine

fluoxetine and dibucaine

fluoxetine has been researched along with dibucaine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L1
Bellampalli, SS; Hu, Y; Khanna, R; Kitamura, N; Musharrafieh, R; Tuohy, P; Wang, J; Zhang, J1
Bauer, L; Canard, B; Coutard, B; de Boer, SM; Egan, D; Lelieveld, D; Lichière, J; Lyoo, HR; Maté, MJ; Omta, W; Ulferts, R; van der Linden, L; van Kuppeveld, FJ1
Bertozzi, CR; Fox, DM; Riley, LW; Schump, MD1

Other Studies

6 other study(ies) available for fluoxetine and dibucaine

ArticleYear
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship

2013
Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68).
    Journal of medicinal chemistry, 2019, 04-25, Volume: 62, Issue:8

    Topics: Antiviral Agents; Cell Line, Tumor; Cell Survival; Dibucaine; Drug Design; Enterovirus D, Human; Humans; Quinolines; Structure-Activity Relationship

2019
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5

    Topics: Antiviral Agents; Carbazoles; Carrier Proteins; Clopenthixol; Dibucaine; Enterovirus; Fluoxetine; Formoterol Fumarate; HeLa Cells; Humans; Rhinovirus; Viral Nonstructural Proteins; Viral Proteins; Virus Replication

2016
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Ammonium Chloride; Anesthetics, Local; Antitubercular Agents; Biological Transport; Clofazimine; Dibucaine; Fluoxetine; Humans; Hydrogen-Ion Concentration; Macrolides; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Protons; Selective Serotonin Reuptake Inhibitors; Sertraline

2017